Women suffering from mental illness, neuropsychiatric disability, or substance addiction are less likely to undergo gynaecological screening tests for cervical cancer and are more than twice as likely to develop the disease.
Three batches of approximately 80,000 doses of HPV vaccine have been released by Central drugs laboratory (CDL) in, Kasauli, Himachal Pradesh, sources said to ANI
Serum Institute of India Director Prakash Kumar Singh on Thursday presented Made in India HPV Vaccine Cervavac to Union Minister Jitendra Singh at the Union Minister's residence.
Chemotherapy and pembrolizumab have been approved for the treatment of women with metastatic, recurring, or persistent cervical cancer whose tumours express PD-L1. Chemotherapy can be administered with or without bevacizumab. Whether pembrolizumab in this combination provides patients with a
Adar Poonawalla said that the availability of the Human Papillomavirus (HPV) vaccine will be little in number this year, however, it would be boosted next year.
According to MSD, Keytruda is the first cancer immunotherapy to be approved in India for the treatment of cervical cancer and the first immunotherapy to be approved as a first-line treatment for a significant sub-group of patients, who otherwise only had the option of chemotherapy as their t
Researchers have developed a brand-new method for locating and eliminating cancer cells by using synthetic DNA. The procedure was successful in lab tests against cells generated from human cervical cancer, human breast cancer, and mouse malignant melanoma.
Certain vaccine-related issues have been shown by research that medical professionals should address. Young cancer survivors are more likely to eventually develop cervical, oropharyngeal, and a number of other HPV-related malignancies, despite the fact that HPV vaccination rates in this popu
New Delhi [India], December 19 (ANI/NewsVoir): To enable knowledge-sharing around Cervical cancer screening including the benefits of early screening with extended genotyping, BD (Becton, Dickinson, and Company) recently organized the 'Shape the future of Cervical Cancer screening' discussio
The Human Papillomavirus (HPV) CERVAVAC vaccine, for the prevention of cervical cancer, is expected to arrive in India by April at the one-tenth of the cost of internationally branded vaccines in the country, said Dr NK Arora, chairman of the Covid working group, National Technical Adviso